Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06414356 · ClinicalTrials.gov registry record · Phase 4
The Effect of Outpatient Ketamine Infusion on Chronic Neuropathic Pain and PTSD
A Phase 4 study of PTSD and Neuropathic Pain, sponsored by Margaux M. Salas, PhD.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT06414356: Recruiting Phase 4 study of PTSD and Neuropathic Pain, sponsored by Margaux M. Salas, PhD.
NCT06414356 is a Phase 4 study of PTSD and Neuropathic Pain that is actively recruiting participants, run by Margaux M. Salas, PhD. The registered enrollment target is 30 participants, below the 302-participant average among 154 other PTSD trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06414356, a Phase 4 study of PTSD and Neuropathic Pain, is actively recruiting participants, sponsored by Margaux M. Salas, PhD.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is aimed to evaluate outpatient ketamine infusion within a military chronic neuropathic pain population and its effect on PTSD. Currently, this is a pilot study with 30 participants. Participants will be randomized to (1) a moderate dose ketamine, (2) moderate dose ketamine +Mg, or (3) a magnesium control group. Participants will complete self-reported pain and PTSD questionnaires throughout the \~24-week study period. The outlined strategy will provide evidence for the utility of ketamine in neuropathic pain management and pain associated comorbidities within a military population.
Primary Outcome
The DVPRS is a self-report instrument used to assess pain intensity in military personnel, veterans, and other military populations. It was specifically developed for individuals with military backgrounds and is often used in clinical settings to monitor pain levels and treatment effectiveness. The DVPRS consists of a Numeric Rating Scale (NRS) from 0 to 10, where 0 represents "no pain" and 10 represents "worst possible pain." Respondents rate their pain intensity by selecting the number that b
Conditions Studied
Interventions
- DRUG Ketamine
- DRUG Magnesium sulfate
- DRUG Ketamine + Magnesium sulfate
Study Locations (1)
Texas
- Brooke Army Medical Center - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2024-10-02 |
| Est. Completion | 2027-05 |
| Phase | Phase 4 |
What NCT06414356 shows while recruiting
NCT06414356 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 302-participant average among 154 other PTSD trials with a reported enrollment target (90% lower).
The record links to 2 conditions, with PTSD appearing as the primary indexed condition, and to 3 interventions - of which Ketamine is the first listed.
NCT06414356 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06414356 about?
NCT06414356 is a clinical study titled "The Effect of Outpatient Ketamine Infusion on Chronic Neuropathic Pain and PTSD". This study is aimed to evaluate outpatient ketamine infusion within a military chronic neuropathic pain population and its effect on PTSD. Currently, this is a pilot study with 30 participants. Participants will be randomized to (1) a moderate dose ketamine, (2) moderate dose ketamine +Mg, or (3) a ...
What is the current status of trial NCT06414356?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 30 participants. The study started on 2024-10-02. Estimated completion is 2027-05.
What conditions does trial NCT06414356 study?
This clinical trial studies the following conditions: PTSD, Neuropathic Pain.
What interventions are being tested in trial NCT06414356?
The interventions under investigation include: Ketamine (DRUG), Magnesium sulfate (DRUG), Ketamine + Magnesium sulfate (DRUG).
Who is sponsoring clinical trial NCT06414356?
This trial is sponsored by Margaux M. Salas, PhD, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06414356 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for PTSD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06414356's enrollment target sits among peer trials
30 122nd of 154 higher than 25 of 154 other PTSD trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other PTSD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Topiramate in the Treatment of Post Traumatic Stress Disorder (PTSD)
COMPLETED · Phase 4
-
Paroxetine Treatment in Outpatients With Comorbid PTSD and Substance Dependence
COMPLETED · Phase 4
-
Effects of Escitalopram on Autonomic Reactivity in Post Traumatic Stress Disorder
COMPLETED · Phase 4
-
Minocycline for Treatment of Posttraumatic Stress Disorder in Veterans
COMPLETED · Phase 4
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
Treatments for Insomnia in Veterans With PTSD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI